Stock 688217 SHANGHAI RIGHTONGENE BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Shanghai Rightongene Biotechnology Co., Ltd.

Equities

688217

CNE100005212

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 14/05/2024 BST 		5-day change 1st Jan Change
24.86 CNY -0.48% Intraday chart for Shanghai Rightongene Biotechnology Co., Ltd. -6.75% -30.52%
04-26 Shanghai Rightongene Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-29 Shanghai Rightongene Biotechnology Co., Ltd. commences an Equity Buyback Plan for CNY 20 million worth of its shares, under the authorization approved on February 28, 2024. CI

Chart calendar Shanghai Rightongene Biotechnology Co., Ltd.

c3ca68b2e921a711b11e9902edd18.XKzlm7aUz5mgGtzwGvj-GGPnASSroXDm7_MvcgADQtY.FvqH9dTbncvIcpK7aM-tbgWxMlHF5hvT2ZQeM1dVcp89lJ3_j6O_q-d2jQ~d0abe61156ee54be7f89053675346b94

Upcoming events on Shanghai Rightongene Biotechnology Co., Ltd.

22/08/2024 Q2 2024 Earnings Release (Projected)
23/10/2024 Q3 2024 Earnings Release (Projected)
15/04/2025 Q4 2024 Earnings Release (Projected)
24/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Shanghai Rightongene Biotechnology Co., Ltd.

25/04/2024 Q1 2024 Earnings Release
16/04/2024 Q4 2023 Earnings Release
26/10/2023 Q3 2023 Earnings Release
28/08/2023 Q2 2023 Earnings Release
27/04/2023 Q1 2023 Earnings Release
09/04/2023 Q4 2022 Earnings Release
26/10/2022 Q3 2022 Earnings Release
24/08/2022 Interim 2022 Earnings Release
27/04/2022 Q1 2022 Earnings Release
19/04/2022 FY 2021 Earnings Release

Past dividends on Shanghai Rightongene Biotechnology Co., Ltd.

29/11/2023 Annual 0.18 CNY

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million CNY		Released
Forecast
Spread 		0,00


424
374
13.45%		257
296
-13.32%
311

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million CNY		Released
Forecast
Spread 		0,00


71,7
40,0
79.28%		-7,24
39,0
-118.58%
8,00

Earnings before Tax (EBT)
Million CNY		Released
Forecast
Spread 		0,00


71,5
46,0
55.4%		-9,90
45,0
-121.99%
13,0

Net income
Million CNY		Released
Forecast
Spread 		46,0


40,5
42,7
-5.1%		8,12
41,4
-80.39%
12,0

EPS
CNY		Released
Forecast
Spread 		0,92


0,73
0,77
-5.19%		0,15
0,74
-79.73%
0,21

Announcement Date25/02/2227/02/2323/02/24-

Upcoming sector events for Shanghai Rightongene Biotechnology Co., Ltd.

17/07/2024 07:00 VITROLIFE AB: Q2 2024 Earnings Release
29/07/2024 AMOY DIAGNOSTICS CO., LTD.: Q2 2024 Earnings Release (Projected)
31/07/2024 MYRIAD GENETICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 LANTHEUS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 10X GENOMICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 MACCURA BIOTECHNOLOGY CO.LTD: Q2 2024 Earnings Release (Projected)
31/07/2024 SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.: Q2 2024 Earnings Release (Projected)
31/07/2024 DIASORIN S.P.A.: Q2 2024 Earnings Release
04/08/2024 CASTLE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
08/08/2024 SD BIOSENSOR, INC: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Shanghai Rightongene Biotechnology Co., Ltd.

12/05/2024 SD BIOSENSOR, INC: Q1 2024 Earnings Release (Projected)
10/05/2024 14:21 DIASORIN S.P.A.: Q1 2024 Earnings Release
07/05/2024 21:05 MYRIAD GENETICS, INC.: Q1 2024 Earnings Release
02/05/2024 21:05 CASTLE BIOSCIENCES, INC.: Q1 2024 Earnings Release
02/05/2024 12:00 LANTHEUS HOLDINGS, INC.: Q1 2024 Earnings Release
30/04/2024 21:05 10X GENOMICS, INC.: Q1 2024 Earnings Release
29/04/2024 ASSURE TECH (HANGZHOU) CO., LTD.: Q1 2024 Earnings Release
29/04/2024 SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q1 2024 Earnings Release
29/04/2024 SHANDONG ORIENTAL OCEAN SCI-TECH CO., LTD.: Q4 2023 Earnings Release
29/04/2024 ZHEJIANG ORIENT GENE BIOTECH CO.,LTD: Q4 2023 Earnings Release

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688217 Stock
  4. Calendar Shanghai Rightongene Biotechnology Co., Ltd.